North Dakota Administrative Code › Title 33 - State Department of Health › Article 33-06 - Reportable Diseases › Chapter 33-06-01 - Conditions Designated as Reportable › Section 33-06-01-01 - Reportable conditions

Current through Supplement No. 393, July, 2024
All reports and information concerning reportable conditions
				  are confidential and not open to inspection. The following designated
				  reportable conditions must be reported to the department of health and human
				  services by the persons designated in
				  chapter
				  33-06-02. If any
				  reportable condition is designated by an asterisk, an appropriate sample or
				  isolate must be submitted to the public health laboratory in addition to the
				  required report.
1. Acute flaccid
				myelitis.
2. Alpha-gal
				syndrome.
3. Anthrax*.
4. Arboviral infection.
5. Botulism*.
6. Brucellosis*.
7. Campylobacteriosis.
8. Cancer, all malignant and in situ
				carcinomas; in addition, all benign cancers of the central nervous system,
				pituitary gland, pineal gland, and craniopharyngeal duct. Carcinoma in situ of
				the cervix is not collected. Basal or squamous cell carcinoma is not collected
				unless diagnosed in the labia, clitoris, vulva, prepuce, penis, or
				scrotum.
9. Candida
				auris*.
10. CD4 test results
				(all).
11. Chickenpox
				(varicella).
12. Chlamydial
				infections.
13. Cholera*.
14. Cluster of severe or unexplained illness
				or deaths.
15.
				Coccidioidomycosis.
16.
				Creutzfeldt-Jakob disease.
17.
				Critical congenital heart disease (CCHD).
18. Cryptosporidiosis.
19. Cyclosporiasis.
20. Diphtheria*.
21. E. coli, shiga
				toxin-producing*.
22. Fetal alcohol
				syndrome (FAS).
23. Foodborne or
				waterborne outbreaks.
24.
				Giardiasis.
25.
				Glanders*.
26. Gonorrhea.
27. Haemophilus influenzae infection
				(invasive infection with haemophilus influenzae isolated from blood, cerebral
				spinal fluid, or other normal sterile site)*.
28. Hantavirus*.
29. Hemolytic uremic syndrome.
30. Hepatitis (A*, B, C, D, and E), including
				hepatitis B and C nucleic acid test result (detectable or nondetectable) and
				hepatitis C genotype results.
31.
				Human immunodeficiency virus (HIV) infection, including acquired
				immunodeficiency syndrome (AIDS). (Any positive HIV test result, including gene
				sequencing and drug resistance patterns.) Human immunodeficiency virus (HIV)
				nucleic acid test result (including nondetectable).
32. Influenza (electronic laboratory
				reporting, novel cases, and pediatric deaths)*.
33. Laboratory incidences involving the
				possible release of category A bioterrorism agents or novel influenza viruses
				into the laboratory environment.
34. Lead blood level results (all).
35. Legionellosis.
36. Leptospirosis.
37. Listeriosis*.
38. Malaria*.
39. Measles (rubeola)*.
40. Melioidosis*.
41. Meningococcal disease (invasive infection
				with Neisseria meningitidis isolated from blood, cerebral spinal fluid, or
				other normal sterile site)*.
42.
				Mumps*.
43. Neonatal abstinence
				syndrome (NAS).
44. Nipah viral
				infections*.
45. Nosocomial
				outbreaks.
46. Novel severe acute
				illness*.
47. Organisms resistant
				to carbapenem or with emerging antimicrobial resistance*.
48. Orthopoxvirus*.
49. Overdose.
50. Pertussis.
51. Plague*.
52. Poliomyelitis*.
53. Pregnancy in a person infected with
				hepatitis B or C, HIV, or syphilis.
54. Q fever*.
55. Rabies (animal or human*), all
				results.
56. Respiratory panel test
				result (electronic laboratory reporting).
57. Respiratory syncytial virus (electronic
				laboratory reporting and pediatric deaths).
58. Rubella*.
59. Salmonellosis*.
60. Scabies outbreaks in
				institutions.
61. Severe acute
				respiratory syndrome-associated coronavirus disease (electronic laboratory
				reporting and pediatric deaths)*.
62. Shigellosis*.
63. Staphylococcus aureus, vancomycin
				resistant and intermediate resistant (VRSA and VISA)*.
64. Staphylococcus enterotoxin B
				intoxication*.
65. Streptococcus
				pneumoniae infections (invasive infection isolated from blood, cerebral spinal
				fluid, or other normal sterile site)*.
66. Suicide and suicide attempts.
67. Syphilis.
68. Tetanus.
69. Tickborne diseases*.
70. Trichinosis.
71. Tuberculosis (tuberculosis infection
				caused by Mycobacterium tuberculosis or Mycobacterium bovis)*. Laboratories
				that receive specimens for tuberculosis testing shall report all results
				obtained by an appropriate procedure. This includes all smear results for
				acid-fast bacilli, results of cultures to look for M. tuberculosis complex, and
				results of rapid methodologies, including nucleic acid amplifications which are
				performed when M. tuberculosis complex is suspected (only via electronic
				laboratory reporting). Positive results of tests performed by purified protein
				derivative antigen and all results by any other test approved for the purpose
				of identifying tuberculosis infection, (i.e. interferon gamma release assay)
				with corresponding values as available.
72. Tularemia*.
73. Tumors of the central nervous
				system.
74. Typhoid
				fever*.
75. Unexplained or emerging
				critical illness or death.
76.
				Vibriosis*.
77. Violent
				death.
78. Viral hemorrhagic
				fevers.
79. Weapons of mass
				destruction suspected event.
80.
				Yellow fever*.
General Authority:
NDCC 23-07-01
Law Implemented:
NDCC
					 23-07-01